C

Capricor Therapeutics

D
CAPR
USD
-0.165
(-3.1977%)
Market Closed
6,256.00
Volume
-1.38
EPS
-
Div Yield
-5.612360
P/E
162,531,955.35
Market Cap
Today
-3.1977%
1 Week
19.784%
1 Month
23.333%
6 Months
-26.327%
12 Months
-15.909%
Year To Date
2.147%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
P
PLUG
-0.035
(-1.6706%)
USD
A
AMRS
-0.0065
(-10.5519%)
USD
F
FCEL
-0.0322
(-6.5195%)
USD
B
BLDP
0.04
(2.3256%)
USD
B
BEEM
-0.23
(-4.2991%)
USD
B
BEP
0.11
(0.4195%)
USD
R
RUN
-1.19
(-5.8592%)
USD
E
ENPH
-2.41
(-2.0122%)
USD
S
SEDG
-0.48
(-2.214%)
USD

Title:
Capricor Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Do you need help or have a question?
Contact Us